Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...